![Loretta Itri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Loretta Itri
Nessuna posizione attualmente
Profilo
Loretta M. Itri è Chief Medical Officer di Immunomedics, Inc. In passato ha ricoperto la posizione di Chief Medical Officer presso Genta, Inc, Senior Vice President-Medical & Regulatory Affairs presso il Robert Wood Johnson Pharmaceutical Research Institute, Chief Medical Officer & Senior VP-Clinical Affairs presso Ortho Biotech Products LP, Senior Director-Clinical Investigations presso Hoffmann-La Roche, Inc, EVP-Global Health Science & Regulatory Affairs presso The Medicines Co. e Member-Scientific Counselor presso National Cancer Institute. Il Dr. Itri ha ricevuto un dottorato dal New York Medical College e una laurea presso la Long Island University.
Precedenti posizioni note di Loretta Itri
| Società | Posizione | Fine |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2024 |
| THE MEDICINES COMPANY | Consigliere Generale | 01/05/2019 |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
| PHARMACYCLICS, INC. | Direttore/Membro del Consiglio | 09/08/2006 |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Direttore Tecnico/Scientifico/R&S | 01/01/2001 |
Formazione di Loretta Itri
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
Ortho Biotech, Inc. | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Pharmaceutical Research Institute
 Robert Wood Johnson Pharmaceutical Research Institute BiotechnologyHealth Technology Engages in pharmaceutical research and development | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
